Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
This action is responsive to Applicant's amendments/remarks filed 07/07/2026.
Claims 1, 2, 6, 9, and 12-18 are currently pending, of which claims 13-15 are withdrawn.
Claims 1, 2, 6, 9, 12, and 16-18 are currently under examination.
The rejection of claims 1-5, 7, and 8 under 35 U.S.C. 103 as being unpatentable over Hiroaki (WO 2021/131810 A1) is withdrawn in view of the above amendments.
The rejection of claims 1-3, 10, and 11 under 35 U.S.C. 103 as being unpatentable over Miki (US 2018/0319726 A1) is withdrawn in view of the above amendments.
The rejection of claims 3 under 35 U.S.C. 103 as being unpatentable over Okamoto (JP 2019112507 A) is withdrawn in view of the cancellation of claim 3.
The rejection of claims 1, 2, 6, 9, and 12 under 35 U.S.C. 103 as being unpatentable over Okamoto (JP 2019112507 A) is withdrawn in view of the above remarks.
The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application.
Claim Objections
Claim 17 is objected to because of the following informalities:
Claim 17 recites “atmoshperic”. Applicant is suggested to revise it as “atmospheric” for clarity.
Appropriate correction is required.
Claim Rejections - 35 USC § 102 & 103
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
(a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
1. Claims 1, 2, 6, 12, and 16-18 are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as being unpatentable over Miyaoka (JP 2019065223 A, hereinafter Miyaoka).
Regarding claims 1, 2, and 6, Miyaoka teaches a cleaning agent composition consisting of 10-30 mass % of C4F9OCH3 (NOVEC7100) and 70-90 mass% of (Z)-1-chloro-3,3,3-trifluoropropene (1233Z) ([0056], [0059], Examples 1-4, Table 1-2), which fall within the claimed ranges of “0.1 to 40.5 mass%” and “59.5 to 99.9 mass%”. The C4F9OCH3 in Miyaoka reads on the claimed methyl nonafluorobutyl ether.
The court has held that “Products of identical chemical composition can not have mutually exclusive properties.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). A chemical composition and its properties are inseparable. Therefore, if the prior art teaches the identical chemical structure, the properties applicant discloses and/or claims are necessarily present. Id. See MPEP 2112.01 II. "Where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established." In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433 (CCPA 1977). See MPEP 2112.01 I.
Therefore, the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would be present in the identical composition (i.e. the composition consisting of 10-30 mass % of C4F9OCH3 and 70-90 mass% of 1233Z in Examples 1-4) as taught by Miyaoka.
In any event, Miyaoka’s teaching does not sufficiently anticipate the claimed properties, the claimed properties are nevertheless obvious over Miyaoka.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would flow naturally from the teaching of Miyaoka, because the teaching of Miyaoka provides substantially the same composition consisting of the same amount of methyl nonafluorobutyl ether and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
Regarding claims 1, 2 and 12, Miyaoka teaches a cleaning agent composition consisting of 10-30 mass % of 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)ethane (AE-3000) and 70-90 mass% of (Z)-1-chloro-3,3,3-trifluoropropene (1233Z) ([0056], [0059], Examples 22-25, Table 1-5), which fall within the claimed ranges of “0.1 to 38.0 mass%” and “62.0 to 99.9 mass %”. The 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)ethane in Miyaoka reads on the claimed 2,2,2-trifluoroethyl-1,1,2,2-tetrafluoroethyl ether.
The court has held that “Products of identical chemical composition can not have mutually exclusive properties.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). See MPEP 2112.01. I and II.
Therefore, the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would be present in the identical composition (i.e. the composition consisting of 10-30 mass % of 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)ethane and 70-90 mass% of 1233Z in Examples 22-25) as taught by Miyaoka.
In any event, Miyaoka’s teaching does not sufficiently anticipate the claimed properties, the claimed properties are nevertheless obvious over Miyaoka.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would flow naturally from the teaching of Miyaoka, because the teaching of Miyaoka provides substantially the same composition consisting of the same amount of 2,2,2-trifluoroethyl-1,1,2,2-tetrafluoroethyl ether and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
Regarding claims 16 and 17, Miyaoka teaches a cleaning agent composition consisting of 10-20 mass % of C4F9OCH3 (NOVEC7100) and 80-90 mass% of (Z)-1-chloro-3,3,3-trifluoropropene (1233Z) ([0056], [0059], Examples 1-3, Table 1-2), which falls within the claimed range of “at least 80 mass %”.
Miyaoka also teaches a cleaning agent composition consisting of 10-20 mass % of 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)ethane (AE-3000) and 80-90 mass% of (Z)-1-chloro-3,3,3-trifluoropropene (1233Z) ([0056], [0059], Examples 22-24, Table 1-5), which falls with the claimed range of “at least 80 mass %”.
The court has held that “Products of identical chemical composition can not have mutually exclusive properties.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). See MPEP 2112.01. I and II.
Therefore, the claimed property of the composition having an atmospheric boiling point of 38 ᵒC to 46 ᵒC, would be present in the identical composition (i.e. the composition consisting of 10-20 mass % of C4F9OCH3 and 80-90 mass% of 1233Z in Examples 1-3, or the composition consisting of 10-20 mass % of 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)ethane and 80-90 mass% of 1233Z in Examples 22-24) as taught by Miyaoka.
In any event, Miyaoka’s teaching does not sufficiently anticipate the claimed property, the claimed property is nevertheless obvious over Miyaoka.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed property of the composition having an atmospheric boiling point of 38 ᵒC to 46 ᵒC, would flow naturally from the teaching of Miyaoka, because the teaching of Miyaoka provides substantially the same composition consisting of the same amount of the hydrofluoroether (i.e. methyl nonafluorobutyl ether, or 2,2,2-trifluoroethyl-1,1,2,2-tetrafluoroethyl ether), and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
Regarding claim 18, Miyaoka teaches a cleaning agent composition consisting of 10 mass % of C4F9OCH3 (NOVEC7100) and 90 mass% of (Z)-1-chloro-3,3,3-trifluoropropene (1233Z) ([0056], [0059], Example 1, Table 1-2), which falls within the claimed range of “at least 90 mass %”.
Miyaoka also teaches a cleaning agent composition consisting of 10 mass % of 1,1,2,2-tetrafluoro-1-(2,2,2-trifluoroethoxy)ethane (AE-3000) and 90 mass% of (Z)-1-chloro-3,3,3-trifluoropropene (1233Z) ([0056], [0059], Example 22, Table 1-5), which falls with the claimed range of “at least 90 mass %”.
2. Claims 1, 2, 9, and 16-18 are rejected under 35 U.S.C. 102(a)(1)/(a)(2) as anticipated by or, in the alternative, under 35 U.S.C. 103 as being unpatentable over Abbas (US 2012/0329893 A1, hereinafter Abbas).
Regarding claims 1, 2, and 9, Abbas teaches a composition consisting of 90% by weight of 1-chloro-3,3,3-trifluoropropene (HFCO-1233zd) and 10% by weight of nonafluoroethoxybutane (HFE-7200) (Table 1), which falls within the claimed ranges of “89.0 to 99.9 mass %” and “0.1 to 11.0 mass%”. The nonafluoroethoxybutane in Abbas reads on the claimed ethyl nonafluorobutyl ether.
The court has held that “Products of identical chemical composition can not have mutually exclusive properties.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). See MPEP 2112.01. I and II.
Therefore, the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would be present in the identical composition (i.e. the composition consisting of 90% by weight of HFCO-1233zd and 10% by weight of nonafluoroethoxybutane) as taught by Abbas.
In any event, Abbas’s teaching does not sufficiently anticipate the claimed properties, the claimed properties are nevertheless obvious over Abbas.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would flow naturally from the teaching of Abbas, because the teaching of Abbas provides substantially the same composition consisting of the same amount of ethyl nonafluorobutyl ether and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
Regarding claims 16-18, Abbas teaches a composition consisting of 90% by weight of 1-chloro-3,3,3-trifluoropropene (HFCO-1233zd) and 10% by weight of nonafluoroethoxybutane (HFE-7200) (Table 1), which falls within the claimed ranges of “at least 80 mass %” and “at least 90 mass %”.
The court has held that “Products of identical chemical composition can not have mutually exclusive properties.” In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). See MPEP 2112.01. I and II.
Therefore, the claimed property of the composition having an atmospheric boiling point of 38 ᵒC to 46 ᵒC, would be present in the identical composition (i.e. the composition consisting of 90% by weight of HFCO-1233zd and 10% by weight of nonafluoroethoxybutane) as taught by Abbas.
In any event, Abbas’s teaching does not sufficiently anticipate the claimed property, the claimed property is nevertheless obvious over Abbas.
It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed property of the composition having an atmospheric boiling point of 38 ᵒC to 46 ᵒC, would flow naturally from the teaching of Abbas, because the teaching of Abbas provides substantially the same composition consisting of the same amount of the hydrofluoroether (i.e. ethyl nonafluorobutyl ether), and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
3. Claims 1, 2, 6, 9, and 16-18 are rejected under 35 U.S.C. 103 as being unpatentable over Mitsuoka (WO 2020/175565 A1, see US 20210355405 A1, hereinafter Mitsuoka).
Regarding claims 1, 2, and 6, Mitsuoka teaches a solvent composition comprising (Z)1-chloro-3,3,3-trifluoropropene (HCFO-1233zd (Z)) and solvent (B), wherein the mass ratio of HCFO-1233zd (Z) to solvent (B) is from 99/1 to 70/30, and the proportion of the total amount of HCFO-1233zd (Z) and solvent (B) to the total amount of the solvent composition is at least 80 mass % ([0077]).
Mitsuoka also teaches that the proportion of the total amount of HCFO and solvent (B) to the total amount of the solvent composition is preferably from 95 to 100 mass % ([0076]).
Thus, in Mitsuoka, the proportion of the total amount of HCFO-1233zd (Z) and solvent (B) to the total amount of the solvent composition can be 100 mass%. Thus, the solvent composition of Mitsuoka can consist of HCFO-1233zd (Z) and solvent (B), wherein HCFO-1233zd (Z) is in an amount of 70-99 mass% in the solvent composition, and solvent (B) is in an amount of 1-30 mass% in the solvent composition, which fall within the claimed ranges of “59.5 to 99.9 mass%” and “0.1 to 40.5 mass%”.
Mitsuoka teaches that the solvent (B) can be nonafluorobutyl methyl ether (Novec 7100) ([0056]).
Mitsuoka specifically teaches a solvent composition consisting of 70-75 mass% of HCFO-1233zd(Z), and 25-30 mass% of nonafluorobutyl methyl ether (HFE-7100; Novec 7100) (Examples 22, 26, 31, 34, 38, 42, and 45, Table 2), which fall within the claimed ranges of “59.5 to 99.9 mass%” and “0.1 to 40.5 mass%”.
Mitsuoka does not teach that the solvent composition is an azeotropic or azeotrope-like composition, and has a composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C.
However, it would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would flow naturally from the teaching of Mitsuoka, because the teaching of Mitsuoka provides substantially the same composition consisting of the same amount of methyl nonafluorobutyl ether and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
Regarding claims 1, 2, and 9, Mitsuoka teaches a solvent composition comprising (Z)1-chloro-3,3,3-trifluoropropene (HCFO-1233zd (Z)) and solvent (B), wherein the mass ratio of HCFO-1233zd (Z) to solvent (B) is from 99/1 to 70/30, and the proportion of the total amount of HCFO-1233zd (Z) and solvent (B) to the total amount of the solvent composition is at least 80 mass % ([0077]).
Mitsuoka also teaches that the proportion of the total amount of HCFO and solvent (B) to the total amount of the solvent composition is preferably from 95 to 100 mass % ([0076]).
Thus, in Mitsuoka, the proportion of the total amount of HCFO-1233zd (Z) and solvent (B) to the total amount of the solvent composition can be 100 mass%. Thus, the solvent composition of Mitsuoka can consist of HCFO-1233zd (Z) and solvent (B), wherein HCFO-1233zd (Z) is in an amount of 70-99 mass% in the solvent composition, and solvent (B) is in an amount of 1-30 mass% in the solvent composition, which overlap with the claimed ranges of “89.0 to 99.9 mass %” and “0.1 to 11.0 mass%”.
Mitsuoka also teaches that the solvent (B) can be nonafluorobutyl ethyl ether (Novec 7200) ([0056]). Mitsuoka further teaches that the solvent composition consists of HCFO-1233zd (Z) and nonafluorobutyl ethyl ether (HFE-7200; Novec 7200) (Table 2).
Mitsuoka does not teach the solvent composition is an azeotropic or azeotrope-like composition, and has a composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C.
However, it would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed azeotropic or azeotropic-like property and the claimed property of the composition in which a temperature difference of a temperature indicated by a gas-phase line and a temperature indicated by a liquid-phase line is within 2 °C, would flow naturally from the teaching of Mitsuoka, because the teaching of Mitsuoka provides substantially the same composition consisting of the same amount of ethyl nonafluorobutyl ether and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
Regarding claims 16-18, as discussed above, the solvent composition of Mitsuoka can consist of HCFO-1233zd (Z) and solvent (B), wherein HCFO-1233zd (Z) is in an amount of 70-99 mass% in the solvent composition, and solvent (B) is in an amount of 1-30 mass% in the solvent composition, which overlap with the claimed ranges of “at least 80 mass %” and “at least 90 mass %”.
Mitsuoka teaches that the solvent (B) can be nonafluorobutyl methyl ether (HFE-7100; Novec 7100), or nonafluorobutyl ethyl ether (HFE-7200; Novec 7200) ([0056], Table 2).
Mitsuoka does not teach that the solvent composition has an atmospheric boiling point of 38 ᵒC to 46 ᵒC.
However, it would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to reasonably expect that the claimed property of the composition having an atmospheric boiling point of 38 ᵒC to 46 ᵒC, would flow naturally from the teaching of Mitsuoka, because the teaching of Mitsuoka provides substantially the same composition consisting of the same amount of the hydrofluoroether (i.e. methyl nonafluorobutyl ether, or ethyl nonafluorobutyl ether), and the same amount of 1-chloro-3,3,3-trifluoro-1-propene as claimed. Therefore, the invention as a whole would be obvious to a person of ordinary skill in the art.
Response to Arguments
Applicant's arguments with respect to the prior rejections have been considered but are moot, because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. The current rejection utilizes new references, Miyaoka (JP 2019065223 A), Abbas (US 2012/0329893 A1), and Mitsuoka (WO 2020/175565 A1, see US 20210355405 A1).
As stated above, claim 1 is rejected under 35 U.S.C. 103 as being unpatentable over Miyaoka (JP 2019065223 A).
Claim 1 is rejected under 35 U.S.C. 103 as being unpatentable over Abbas (US 2012/0329893 A1).
Claim 1 is rejected under 35 U.S.C. 103 as being unpatentable over Mitsuoka (WO 2020/175565 A1, see US 20210355405 A1).
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to JIAJIA JANIE CAI whose telephone number is 571-270-0951. The examiner can normally be reached Monday-Friday 8:30 am - 5:00 pm.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner' s supervisor, Angela Brown-Pettigrew can be reached on 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JIAJIA JANIE CAI/Examiner, Art Unit 1761
/MATTHEW R DIAZ/Primary Examiner, Art Unit 1761